USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Stichting Radboud universitair medisch centrum

USPTO PatentsView assignee record - 9 granted patents across 10 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Stichting ranks #30,261 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 10 technology areas.

#30,261
of 49,997 US assignees by volume
Top 16%
by Innovation Score (48.9/100)
16.3
avg claims per patent

USPTO PatentsView assignee plate

Corpus R30261 · Foreign Corporation #30,261 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · SPAN-YRS · BOOK-RICH

  • GRANTS-MICRO 9 grants
  • MID-PACK #30,261/49,997
  • PHOTO-FINISH Stealthbits
  • CPC-FOCUS A61P · 10 areas
  • INNOV-PAR 48.9/100
  • CLAIMS-RICH 16.3 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • SPAN-YRS 2021–2025 · 5y
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Stealthbits Technologies LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Stichting

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Stichting's Innovation Score is 48.9/100 (top 16% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Stichting's grants concentrate

Stichting Radboud universitair medisch centrum is a focused PatentsView assignee: 10 CPC subclasses with 44.4% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2021. By volume, Stichting sits between Stealthbits Technologies LLC and Stormtrap, LLC.

Stichting's three-year grant acceleration

Stichting Radboud universitair medisch centrum shows 7 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Stichting's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Stichting holds 9 patents at rank #30,252, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Stichting

By rank, the assignees closest to #30,252 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Stichting's primary technology class.

Stichting's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

49 Top 16% higher than 84% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20212022202320242025 1
USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table
Stichting Radboud universitair medisch centrum patent grants by year, 2015–2025
Year Patents Granted Share of Period
2021 1 11.1%
2022 3 33.3%
2023 1 11.1%
2024 3 33.3%
2025partial year 1 11.1%

Where it ranks

Overall rank by patents

#30,261

of 49,997 tracked assignees

Innovation Score

48.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Stichting Radboud universitair medisch centrum's patent record in context - here's where to go next.

  • Stichting Radboud universitair medisch centrum's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 44.4% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #30,261 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Stichting Radboud universitair medisch centrum against Stealthbits Technologies LLC, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 48.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.